Semaglutide for psoriasis and weight management
Treatments studied
Part of Hormones & metabolism, Skin clinical trials.
This trial tests if semaglutide, a diabetes and weight-loss medication, can improve psoriasis symptoms and reduce inflammation. It may be an option for people with both psoriasis and overweight or obesity, with or without diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Adults 18 years or older with plaque psoriasis affecting at least 3% of body surface area
- Overweight or obese, with a body mass index (BMI) of 25 or higher
- Have not used systemic psoriasis treatments (like methotrexate) for at least 8 weeks
- Have not used biologic therapies (like adalimumab) for at least 3 months
- People with diabetes must have stable medication and an A1C level of 9% or less
- Must not have certain other health issues like severe kidney, liver, heart problems, or history of pancreatitis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if semaglutide, a medicine used for diabetes and weight loss, can help people with both psoriasis and obesity. You may qualify if you have moderate to severe psoriasis, a high body weight, and are of Chinese descent.
This study tests a medication called semaglutide (which helps with weight loss) in people with obesity who have struggled to lose weight before. It will see how much weight participants can lose while taking the drug.
This trial tests whether semaglutide (a medicine that helps control blood sugar and weight) can improve outcomes for people with type 1 diabetes who have a higher body weight. It may help if you have had type 1 diabetes for at least 3 years and have a BMI of 30 or more, or 27 or more with a related health problem.
This study tests if a medication called semaglutide can help people with obesity lose weight by changing the bacteria in their gut. You may be able to join if you have obesity, have tried to lose weight before, and are generally healthy.
This trial tests if a GLP-1 receptor agonist (a type of diabetes medication) can help treat psoriatic arthritis in people who are overweight but do not have diabetes. You might join if you have psoriatic arthritis, a high BMI, and you are of Chinese descent.
This study tracks how semaglutide (an injectable medication that reduces appetite) helps adults lose weight in everyday life. Researchers want to understand how well it works and how safe it is for people starting the treatment.
Hear when a new Psoriasis (PsO) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.